Companies Registration Office

Week of 2026-W11

Irish Corporate Affairs Weekly | Business Post

Irish Corporate Affairs Weekly

CRO Company & Business Formations, Financial Filings & Director Networks — Week of 12–16 March 2026

Source: CRO | Period: 2026-03-12 to 2026-03-16

Weekly | 12–16 March 2026

1,415 Filings, a Seven-Company Healthcare Empire, and a $406m US Tech Royalty Engine — Ireland's Corporate Week in Full

The week of 12–16 March 2026 produced 1,415 financial filings at the CRO — a volume that tells its own story about the scale of Ireland's corporate economy. The headline finds are concentrated in healthcare: Beacon Medical Group Limited filed consolidated accounts showing €16.1m in revenue and a 48% gross margin from its Sandyford campus, while Medical Account Services Limited disclosed €21.4m in turnover — up 18% year-on-year — from its healthcare billing software operation in Dundrum. Meanwhile, Genesys Cloud Services Ireland Limited quietly filed accounts showing $406m in royalty income from European subsidiaries, confirming its role as a critical intellectual property node for a US cloud communications giant. Two new business names were registered — a solicitors' practice and a medical centre — while the courts delivered a planning judgment with implications for the development sector.

1,415

Financial Reports Filed

Consolidated Group Accounts

New Business Names

€21.4m

Top Revenue (Medical Account Services)

$406m

Genesys Cloud Royalty Income

By the Numbers

Metric	Value	Signal
Financial reports received (week)	1,415	Active filing period
Consolidated group accounts filed	9	Group structures active
Highest revenue (Medical Account Services)	€21.4m	+18% YoY
Beacon Medical Group revenue	€16.1m	+1.6% YoY
Genesys Cloud royalty income	$406m	+3.6% YoY
New business names registered	2	Legal + medical
Beacon Medical net assets	€17.3m	Up from €15.0m
Xeinadin Ireland South revenue growth	+88%	€4.7m to €8.8m

Business Post AI Pick: Healthcare Dominates the Filing Week Three of the nine consolidated group accounts filed this week were healthcare entities — Beacon Medical Group, Medical Account Services, and the Classes Lake Pharmacy group. Together they employ over 250 people and generate more than €50m in combined revenue. The pattern suggests that Ireland's private healthcare sector — from clinical services to billing infrastructure — is filing on a compressed annual return cycle, with FY2025 accounts landing in bulk this March.

Pattern of the Week: The Invisible Tech Royalty Machine Genesys Cloud Services Ireland Limited filed accounts showing $406m in royalty income — all earned outside Ireland, from European subsidiaries licensing the company's intellectual property. With 449 employees (up from 396), the entity is simultaneously a major R&D employer and a conduit for cross-border IP flows. The company is loss-making at the entity level ($22.5m pre-tax loss) due to amortisation of $2.9bn in intangible assets, but generates $162m in EBITDA. This is the architecture of modern multinational tax planning: Ireland holds the IP, Europe pays the royalties.

View Full Report →

The Week's Financial Filings: Healthcare, Haulage, and a Rapid-Growth Accountancy Roll-Up

The 1,415 financial statements received by the CRO this week span every corner of the Irish economy — from a Cork pharmacy-and-dairy-farm conglomerate to a Sandyford medical campus to a US cloud company's Irish IP holding vehicle. The nine consolidated group accounts are the most revealing: they show the full picture of group structures, related-party transactions, and multi-entity ownership that individual company filings obscure. Below, the most notable filings ranked by revenue.

Financial Performance: Top Filers This Week

Company	Revenue	Profit/(Loss)	Employees	Auditor	Signal
Medical Account Services Ltd View	€21.4m	€115k	n/d	Ormsby & Rhodes	+18% YoY
Beacon Medical Group Ltd View	€16.1m	€2.31m	97	Grant Thornton	+1.6% YoY
Classes Lake Pharmacy Ltd View	€12.9m	€113k	100	C.M. Calnan & Co.	+4.9% YoY
Xeinadin Ireland South Ltd View	€8.8m	€403k	n/d	n/d	+88% YoY
Genesys Cloud Services Ireland Ltd View	$406m	($22.5m)	449	n/d	IP royalty vehicle
Fortis Construction Ltd	n/d	n/d	n/d	n/d	Construction
Harris's Hill Haulage Ltd	n/d	n/d	n/d	n/d	Transport

Standout: Medical Account Services — Healthcare SaaS Growing at Scale Medical Account Services Limited grew revenue 18% to €21.4m in FY2025 — a rate that outpaces most Irish SMEs and signals genuine market expansion, not just price inflation. The Dundrum-based company provides billing and accounts receivable management for healthcare professionals, with subsidiaries in the UK (Medserv Limited) and Poland (MAS Polska Sp. z.o.o.). Director Cormac Loughrey increased his shareholding from 475 to 525 shares during the year — a small but deliberate signal of confidence. The company holds €4.9m in cash, has minimal debt, and is investing in R&D. The question for FY2026: can it sustain 18% growth as the Irish private healthcare market matures?

Stress Signal: Classes Lake Pharmacy — Profit Compression in a Multi-Sector Group The Classes Lake Pharmacy group — which spans pharmacies, a veterinary practice, a pub, and a dairy farm in Cork — saw profit before tax fall from €228k to €151k despite revenue growing 4.9% to €12.9m. The culprit: interest costs up 13% to €336k, and a €110k loss on disposal of investment property. The group carries €2.2m in long-term debt and has a negative cash position of €86k. Director Dan McCarthy drew €95k in director remuneration (up from €79k), while the group's PAYE/PRSI arrears of €682k due after one year suggest a structured Revenue payment arrangement. The FY2026 accounts will be the real test.

Sector Breakdown: Where the Filings Came From

Based on the week's consolidated and standard filings, the dominant sectors by filing volume were professional services, construction, healthcare, and hospitality — consistent with the March filing cycle for companies with April/June year-ends.

Healthcare & Social Work (86-88)

3 consolidated

Professional Services (69-74)

High volume

Construction (41-43)

Notable

IT & Software (62-63)

Notable

Retail Trade (45-47)

Notable

View All 1,415 Financial Reports →

What the Filings Alone Cannot Tell You

The CRO filing data is the skeleton. Cross-referencing it with court records, property transactions, and Business Post reporting adds flesh. This week, three themes emerge from the connections: the Beacon network's legal exposure, the institutional property market's tentative recovery, and the structural role of Ireland's multinational IP economy in the context of US-Ireland trade tensions.

The Beacon Network: Seven Companies, One Director, One Court Record Beacon Medical Group Limited filed consolidated accounts this week showing €16.1m in revenue and €17.3m in net assets. Director Prof Mark J Redmond (person_num 1343144) sits on the boards of seven Beacon-branded entities: the group holding company, Bagnasco Limited (management services), Cerdera Limited (property development), Beacon Hospital Car Park Limited, Beacon Dialysis Services Limited, Beacon Nursing Homes Limited, and Strikeglade Limited. The network is tightly held: Michael Cullen serves as secretary across all seven. A cross-index search of the judgments database reveals that Beacon Hospital Sandyford Limited — a related party named in the group's own accounts — was a defendant in a 2021 medical negligence case ([2021] IEHC 225). The case was resolved in the hospital's favour on a procedural point, but it illustrates the litigation exposure that comes with operating a private hospital campus at scale. The so what: a seven-company network with €17.3m in net assets and a Sandyford property portfolio is a substantial private healthcare enterprise — and one that has navigated legal challenges without material financial impact.

Institutional Property: DWS Signals a Market Turning Point The Business Post reported on 16 March that DWS, the Deutsche Bank-owned asset manager, is seeking €220m for two Dún Laoghaire apartment schemes it acquired from the Cosgrave Group for €195m in 2020. That 12.8% premium — after six years of holding — is modest by historical standards, but the significance lies in the timing: CBRE Ireland forecasts more than €800m in residential investment transactions in 2026, double the 2025 level. The CRO data corroborates this: Beacon Medical Group's investment property portfolio was revalued upward by €255k to €4.955m in FY2025, consistent with a broader commercial property recovery in the Sandyford/D18 corridor. Watch for further institutional disposals in the coming months as funds that acquired Irish residential assets in 2019–20 begin to exit.

Ireland's IP Economy: Genesys Cloud and the Taoiseach's Washington Visit Genesys Cloud Services Ireland Limited filed accounts showing $406m in royalty income — all earned from European subsidiaries licensing the company's intellectual property. The entity employs 449 people (up 13.4% from 396), spending $119.5m on R&D in FY2025. This is the same week the Taoiseach travelled to Washington to stress the scale of Irish investment in the US, as reported by the Business Post (Taoiseach to stress scale of Irish investment in US). The connection: Genesys Cloud is a US-owned entity using Ireland as its European IP hub — exactly the kind of structure that generates the corporation tax revenues the Taoiseach was defending. A $406m royalty engine employing 449 Irish-based R&D workers is a concrete example of the bilateral economic relationship at stake.

Accountancy Roll-Up: Xeinadin's Irish Expansion Accelerates Xeinadin Ireland South Limited filed accounts showing revenue of €8.8m for FY2025 — up 88% from €4.7m the prior year. Xeinadin is a UK-based accountancy consolidator that has been acquiring Irish practices; the Ireland South entity covers Munster and the south-east. An 88% revenue jump in a single year is not organic growth — it is acquisition-driven, consistent with the Xeinadin group's stated strategy of buying regional accounting firms. The so what: a UK-headquartered roll-up is quietly consolidating the Irish accountancy market, and the CRO filings are the first public signal of how fast it is moving. Watch for further Xeinadin entity filings in the coming quarters.

The Radar: Three Signals Worth Watching

Healthcare Billing Infrastructure: A Quiet SaaS Boom Medical Account Services Limited (€21.4m, +18%) and the broader pattern of healthcare-adjacent filings this week suggest that Ireland's private healthcare billing and administration sector is growing faster than the clinical sector itself. With subsidiaries in the UK and Poland, Medical Account Services is building a cross-border healthcare SaaS platform from a Dundrum base. Watch for: further international expansion announcements and potential acquisition activity as the company deploys its €4.9m cash reserve.

Multi-Sector Rural Conglomerates: Profit Pressure Building The Classes Lake Pharmacy group — pharmacy, vet, pub, dairy farm — is not unique. Several of this week's standard filings show similar multi-sector rural operators with compressed margins, rising interest costs, and PAYE/PRSI arrears structured as long-term liabilities. This is a pattern of deferred financial stress, not acute crisis. Watch for: a wave of restructuring or consolidation among rural multi-sector operators as interest rates remain elevated through 2026.

New Business Names: Legal and Medical Services Registering Two new business names registered this week: O'Mahonys Solicitors (Deansgrange, Dublin) and Glencairn Medical Centre (Leopardstown Valley, Dublin 18). Both are in the D18/south Dublin corridor — the same geography as the Beacon Medical campus. A solicitors' practice and a medical centre registering in the same week in the same postcode is not coincidence; it reflects the continued build-out of professional services infrastructure in the Sandyford/Leopardstown business district. Watch for: further professional services registrations in D18 as the area's commercial density increases.

View Full Report →

Two Companies, Two Models, One Week

Two companies filed this week that deserve more than a table row. Beacon Medical Group Limited represents the Irish private healthcare model at its most mature: a multi-entity campus operation with investment property, dialysis services, and a fertility clinic joint venture, all held under a single director network. Medical Account Services Limited represents something newer: a healthcare technology company growing at SaaS rates from a Dundrum base, with international subsidiaries and a director who is quietly buying more of his own company. Both filed consolidated accounts this week. Both are worth understanding in full.

Beacon Medical Group Limited — The Sandyford Healthcare Empire

Beacon Medical Group Limited (CRO: 456723) is the holding company for a cluster of healthcare and property entities based at Beacon Mall, Sandyford, Dublin 18. Its principal activity is healthcare and related services, delivered through subsidiaries including Beacon Dialysis Services Limited, Beacon Hospital Car Park Limited, Cerdera Limited (property development), and Bagnasco Limited (management services). The group also holds a 50% stake in Beacon Concourse Development Limited, which is constructing an IVF clinic. Directors Prof Mark J Redmond and Michael Cullen have been at the helm since 2008 and 2024 respectively; neither drew director remuneration in FY2025.

Metric	FY2025	FY2024	Change
Revenue	€16.10m	€15.85m	+1.6%
Gross profit margin	48%	47%	+1pp
Operating profit	€2.49m	€2.91m	−17%
Profit after tax	€2.31m	€2.02m	+14.4%
Net assets	€17.29m	€14.98m	+15.4%
Cash at bank	€2.43m	€1.13m	+114%
Employees	97	95	+2
Investment property (fair value)	€4.96m	€4.70m	+€255k

Reading Between the Lines: A Holding Company That Earns Its Keep The operating profit fell 17% despite revenue growth — a sign that administrative costs (€5.29m, up from €4.62m) are growing faster than the top line. But the net profit figure tells a different story: €2.31m after tax, up 14.4%, boosted by a €255k fair value gain on investment property and the elimination of €623k in bank interest that weighed on FY2024. The group repaid all bank debt in FY2024 (€9.7m) and is now debt-free. Cash doubled to €2.43m. The parent company itself runs at a small loss (€30k), which is normal for a holding structure — the subsidiaries carry the earnings. The group's related-party transactions reveal the full picture: €1.845m advanced to Beacon Medical Holdings (a related party by common directors), and €250k in management charges invoiced to Beacon Care Fertility Limited. This is a tightly integrated network, not a passive holding company.

The question for FY2026: with bank debt eliminated and cash building, will the group deploy capital into the IVF clinic joint venture, acquire further healthcare assets, or distribute to shareholders? The accounts are silent on post-balance-sheet events — which means the answer will only emerge in next year's filing.

Key People This Period

Name	Role	Notable Activity	Connections
Prof Mark J Redmond	Director	Filed consolidated FY2025 accounts for Beacon Medical Group; holds 14,732 shares (unchanged)	Beacon Medical Group, Bagnasco, Cerdera, Beacon Dialysis, Beacon Nursing Homes, Strikeglade
Michael Cullen	Director & Secretary	Secretary across entire Beacon network; holds 25,313 shares (unchanged); approved FY2025 accounts Jan 2026	Beacon Medical Group, Beacon Hospital Car Park, Strikeglade
Cormac Loughrey	Director & Secretary	Increased shareholding from 475 to 525 shares in FY2025; advanced €181,797 director loan to company	Medical Account Services
John Loughrey	Director	Co-director of Medical Account Services; holds 50 shares (unchanged)	Medical Account Services
Dan McCarthy	Director & Secretary	Drew €95k director remuneration (up from €79k); director loan reduced from €130k to €80k	Classes Lake Pharmacy, Dan McCarthy Veterinary
Caroline McSweeney	Director	Co-director of Classes Lake Pharmacy group; approved FY2025 accounts Feb 2026	Classes Lake Pharmacy

One to Watch: Xeinadin Ireland South Limited

Xeinadin Ireland South Limited

CRO: 645281 | Registered: Cork | NACE: Accounting & Bookkeeping (6920) | Auditor: n/d | FY end: May 2025

Metric	FY2025	FY2024
Revenue	€8.8m	€4.7m
Profit before tax	€403k	€375k
Revenue growth	+88%	—

Xeinadin Ireland South Limited is the Irish southern entity of Xeinadin Group, a UK-headquartered accountancy consolidator that has been acquiring regional accounting practices across Ireland and the UK. The company provides contract revenue from customers — the standard descriptor for an acquired-practice revenue model. An 88% revenue jump in a single year is not organic; it reflects acquisitions completed during FY2025.

Why it matters: Xeinadin is quietly consolidating the Irish accountancy market from the outside. Unlike the Big Four or mid-tier firms that compete on brand, Xeinadin competes on acquisition price — buying practices from retiring partners and integrating them into a shared services model. The CRO filing is the first public signal of how fast the Ireland South entity is growing. With €8.8m in revenue and a 4.6% profit margin, the entity is profitable but thin — consistent with a roll-up model that prioritises scale over margin in the early years.

The number that matters: €8.8m in revenue from a standing start of €4.7m. That is not a company growing — it is a company being assembled. Watch for further Xeinadin entity filings in the coming quarters as the group extends its Irish footprint beyond Munster.

Courts, Property, and the Week Ahead

The Irish Courts

The week of 12–16 March produced one High Court judgment of direct relevance to the business community: a planning law challenge that marks the third iteration of litigation against An Coimisiún Pleanála (Ireland's planning authority). For companies in the construction and development sectors, the persistence of this litigation is a material risk factor — planning delays and legal uncertainty add cost and time to any project that requires a planning decision.

Citation	Parties	Subject	Why It Matters
[2026] IEHC 156	Doyle and Ors v An Coimisiún Pleanála [No. 3]	Planning law challenge (third iteration)	Ongoing legal pressure on planning authority decisions; signals systemic challenge to planning process
[2021] IEHC 225	Evans v Beacon Hospital Sandyford Limited	Medical negligence — third party notice	Historical case involving Beacon Hospital Sandyford (related party to this week's filer); hospital succeeded on procedural grounds

Planning Law: The Third Iteration Signal Doyle v An Coimisiún Pleanála [No. 3] — delivered by Humphreys J. on 13 March 2026 — is the third time this case has come before the High Court. Repeated litigation against the planning authority is a structural feature of the Irish development landscape, not an anomaly. For companies like Fortis Construction Limited and Cerdera Limited (Beacon's property development subsidiary), planning uncertainty is a live operational risk. The so what: every additional iteration of planning litigation adds months to project timelines and thousands in legal costs — a hidden tax on Irish construction.

Property Markets & Plans

The residential investment market showed signs of recovery this week, with the Business Post reporting that DWS — the Deutsche Bank-owned asset manager — is seeking €220m for two Dún Laoghaire apartment schemes it acquired for €195m in 2020. That 12.8% premium over six years is modest, but the signal matters: institutional funds that bought Irish residential assets at the bottom of the cycle are beginning to exit, and CBRE Ireland forecasts €800m+ in residential investment transactions in 2026 — double 2025 levels. The property register shows continued activity in the D18 corridor, consistent with the commercial recovery visible in Beacon Medical Group's investment property revaluation.

Address	Price	Date	Type	Note
150 Castle Ave, Clontarf, Dublin 3	€2.27m	19 Feb 2026	Residential	High-value residential sale, north Dublin
27 Kincora Rd, Clontarf, Dublin 3	€1.525m	20 Feb 2026	Residential	Premium residential, Clontarf
Dún Laoghaire apartment schemes (2 blocks)	€220m (guide)	Mar 2026	Residential investment	DWS / Deutsche Bank disposal; acquired €195m in 2020

Institutional Exit: What DWS Tells Us About the 2026 Market The DWS Dún Laoghaire sale is not just a property transaction — it is a market signal. When a fund with €1 trillion in assets under management decides to exit Irish residential property at a 12.8% premium after six years, it is telling you that the market has recovered enough to justify a sale, but not enough to justify holding further. The CBRE forecast of €800m+ in 2026 residential investment transactions suggests this is the beginning of a wave, not a one-off. For developers, this is positive news: institutional capital is returning to the Irish residential market. For tenants, it is more ambiguous: institutional ownership at scale tends to prioritise yield over affordability.

The Week Ahead

The week of 12–16 March 2026 was, at its core, a week about the architecture of the Irish economy. Three themes dominated: the maturation of private healthcare as a corporate sector (Beacon Medical, Medical Account Services, Classes Lake Pharmacy); the structural role of US-owned IP holding vehicles in Ireland's tax base (Genesys Cloud); and the early signs of institutional property market recovery (DWS, Beacon Medical's investment property revaluation). These are not separate stories — they are three facets of the same underlying reality: Ireland's economy is increasingly organised around high-value services, IP, and professional infrastructure, with the CRO filings as the public record of that organisation.

  The Bottom Line
  The single most important takeaway from this week's CRO data is not any individual company — it is the pattern. Healthcare is consolidating (three consolidated group accounts in one week). Accountancy is being rolled up from the outside (Xeinadin). IP is being centralised in Ireland by US multinationals (Genesys Cloud). And the property market is recovering, slowly, from the bottom. Ireland's corporate economy in March 2026 is one of quiet structural change — visible only to those who read the filings.

What to watch in the coming weeks: (1) Further Xeinadin entity filings as the UK roll-up extends its Irish footprint — the Ireland South entity's 88% revenue growth suggests more acquisitions are in the pipeline. (2) Beacon Medical Group's IVF clinic joint venture (Beacon Concourse Development Limited) — the group is now debt-free and cash-building; a capital deployment decision is coming. (3) The DWS Dún Laoghaire sale process — if it closes at or above the €220m guide price, it will confirm that institutional appetite for Irish residential assets has returned in earnest.

View Full Report →